UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 5, 2024 4:30 P.M.
Form: S-3
CIK: 0001388320
Company Name: Actinium Pharmaceuticals, Inc.
File Number: 333-273911